Sumit K Subuhdi

21PUBLICATIONS
181CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 15, 2026
Cardiometabolic health's influence on the efficacy of pre-operative hormone therapy for men with localized high-risk prostate cancer.

|Oct 14, 2026
Immune biomarkers of response and resistance to ipilimumab and nivolumab in metastatic castration-resistant prostate cancer.

|May 16, 2026
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial.

|May 07, 2026
Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

|Nov 07, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy.

Neha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida

|Oct 11, 2025
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.

Xiaolei Shi, Jarey H Wang, Brian F Chapin

Pageof 4

Frequent Collaborators

7 joint publications

Bilal A Siddiqui

7 joint publications

Ana M Aparicio

5 joint publications

Padmanee Sharma

5 joint publications

Christopher L Logothetis